Hanger Orthopedic Group Inc. (NYSE:HGR) delivered a profit and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. The revenue miss is a negative sign to shareholders seeking high growth out of the company.
Hanger Orthopedic Group Inc. Earnings Cheat Sheet
Results: Adjusted Earnings Per Share increased 27.27% to $0.28 in the quarter versus EPS of $0.22 in the year-earlier quarter.
Revenue: Rose 7.08% to $233.54 million from the year-earlier quarter.
Actual vs. Wall St. Expectations: Hanger Orthopedic Group Inc. reported adjusted EPS income of $0.28 per share. By that measure, the company beat the mean analyst estimate of $0.25. It missed the average revenue estimate of $236.77 million.
Quoting Management: “We are pleased with our 12% adjusted EPS growth in the quarter and with our 7% top-line growth, which took us above $1 billion in trailing 12 months sales for the first time in our history,” commented Vinit K. Asar, President and Chief Executive Officer of Hanger. “While same center sales growth in our Patient Care segment was affected by the high 2012 comparison and severe weather, our underlying sales momentum remains strong. We still expect same center sales growth of 3% to 5% for the Patient Care segment for the full year. Within our Products & Services segment, our rehabilitative solutions business delivered another quarter of year-over-year growth, offset by a decline in the distribution business. We expect Products & Services sales to improve in the remainder of the year due to an increased focus on growth and execution driven by our realignment of the segment. Integration of the large volume of O&P acquisitions closed in late 2012 has gone smoothly, which when combined with overall organic growth and effective cost control, allowed us to deliver double digit EPS growth in the quarter. In our previous earnings call, we indicated that the impact of sequestration on our 2013 EPS would be approximately $0.03 per share, net of reductions in discretionary spending aimed at mitigating the impact. We now believe that we can absorb this negative impact through further cost reduction and growth initiatives in our newly reorganized structure. As a result, we are reaffirming our previously issued financial guidance for 2013. Despite headwinds like sequestration, we remain focused on delivering quality care for our patients and continued growth for our shareholders.”
Key Stats (on next page)…
Revenue decreased 14.2% from $272.2 million in the previous quarter. EPS decreased 51.72% from $0.58 in the previous quarter.
Looking Forward: Analysts have a neutral outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings is a profit of $0.56 and has not changed. For the current year, the average estimate has moved up from a profit of $1.99 to a profit of $2.05 over the last ninety days.
Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)